The K–M analysis revealed that the high CK5/6 and p53 expression groups showed significantly lower bladder cancer progression-free rates compared to their counterparts (p = 0.039 and p < 0.001, respectively; Figure 2d). The gene discussed is KRT5; the disease is urinary bladder cancer.